<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29170" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Coral Snake Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hessel</surname>
            <given-names>Matthew M.</given-names>
          </name>
          <aff>Baylor Scott &#x00026; White Memorial Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McAninch</surname>
            <given-names>Scott A.</given-names>
          </name>
          <aff>Baylor Scott &#x00026; White Health Care</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Hessel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Scott McAninch declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29170.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Coral snakes are members of the Elapidae family, and 40 to 50 species exist in the Americas. In the United States (US),&#x000a0;3 types predominate: Micrurus fulvius (eastern coral snake, located in Florida and the southeast US) and Micrurus tener (Texas coral snake, located in Texas and Northwestern Mexico), and Micruroides euryxanthus (Sonoran coral snake, located in the Southeastern&#x000a0;US and the state of Sonora, Mexico) inhabit the US. Coral snakes in North America (north of Mexico City) are recognized by their circumferential bands (noncircumferential shape is found on the nonvenomous shovel-nosed snake) of red, yellow, and black. This activity reviews coral snake toxicity and its presentation and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the pathophysiology of coral snake toxicity.</p></list-item><list-item><p>Assess&#x000a0;the presentation of a patient with coral snake toxicity.</p></list-item><list-item><p>Assess the treatment options for coral snake toxicity.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by coral snake toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29170&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29170">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29170.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Coral snakes are members of the Elapidae family, and 40 to 50 species exist in the Americas. In the United States (US),&#x000a0;3 types predominate:</p>
        <list list-type="order">
          <list-item>
            <p><bold><italic toggle="yes">Micrurus fulvius:&#x000a0;</italic></bold>eastern coral snake, located in Florida and the southeast US)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Micrurus tener:</bold>&#x000a0;</italic>Texas coral snake, located in Texas and Northwestern Mexico)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Micruroides euryxanthus:</bold>&#x000a0;</italic>Sonoran coral snake located in the Southeastern US and the state of Sonora, Mexico)&#x000a0;<xref ref-type="bibr" rid="article-29170.r1">[1]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Coral snakes in North America (north of Mexico City) are recognized by their circumferential bands (noncircumferential shape is found on the non-venomous shovel-nosed snake) of red, yellow, and black (see <bold>Image</bold>. Coral Snake). In North American snakes only, the color sequence may distinguish the venomous coral snake from non-venomous snakes, such as the king snake, whose pattern is "red on black," and is demonstrated by the mnemonic "red on yellow, kills a fellow; red on black, venom lack." Coral snake envenomations are relatively uncommon compared to their pit viper counterparts. However, coral snake venom is very potent and may result in a delayed onset of significant neurotoxicity and respiratory failure.<xref ref-type="bibr" rid="article-29170.r2">[2]</xref></p>
      </sec>
      <sec id="article-29170.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The venom of <italic toggle="yes">M. fulvius</italic> and<italic toggle="yes"> M. tener </italic>is a highly potent neurotoxin.&#x000a0;<italic toggle="yes">M. euryxanthus&#x000a0;</italic>envenomation is not known to cause significant symptoms in humans, although this species does boast a protective sonic warning capability called a "microfart" (caused by air expulsion from its cloaca). The incidence of significant coral snake envenomation is less than that of pit viper bites for several reasons. Unlike pit vipers, coral snakes are more elusive and will often retreat from any signs of danger rather than confront any potential threats. Hence, coral snake bites commonly occur after the intentional handling of the snake by humans or harassment by curious animals.&#x000a0;</p>
      </sec>
      <sec id="article-29170.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Only 25 to 50 of the approximately 9000 total snake bites in the US are due to coral snakes.&#x000a0;<italic toggle="yes">M. fulvius </italic>and <italic toggle="yes">M. tener</italic> account for all clinically significant coral snake bites reported in the US. Only one death due to coral snake envenomation has been reported in North America in the recent past.<xref ref-type="bibr" rid="article-29170.r3">[3]</xref></p>
      </sec>
      <sec id="article-29170.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Unlike pit vipers, whose venom causes local tissue necrosis and coagulopathy, coral snake venom gains systemic access through the lymphatic veins to cause neurotoxicity and respiratory muscle weakness using competitive inhibition of the nicotinic acetylcholine receptors at the neuromuscular junction.&#x000a0;<xref ref-type="bibr" rid="article-29170.r4">[4]</xref></p>
      </sec>
      <sec id="article-29170.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Both presynaptic and postsynaptic inhibition (by alpha neurotoxins) have been documented. Additionally, phospholipase A2 may cause myotoxicity and rhabdomyolysis.<xref ref-type="bibr" rid="article-29170.r5">[5]</xref></p>
      </sec>
      <sec id="article-29170.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>When a victim presents with a reported coral snake bite or mucous membrane exposure to its venom, it is important to determine when the bite occurred, as neurotoxic effects and respiratory insufficiency may be delayed up to 13 hours.<xref ref-type="bibr" rid="article-29170.r6">[6]</xref> If possible, the identity of the snake should be verified through photographic images. Initial presenting symptoms may include mild pain at the bite site (no puncture marks may be present), nausea, vomiting, dizziness, and abdominal pain. Neurotoxicity may present with progressive motor deficits, including cranial nerve deficits, such as ptosis, dysarthria, and dysphagia, as well as descending muscle weakness. Importantly, patients should be closely monitored for signs of respiratory muscle weakness with pulmonary insufficiency; this is the most life-threatening complication of coral snake envenomation.</p>
      </sec>
      <sec id="article-29170.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of coral snake envenomation victims should focus on the assessment of the development of neurologic deficits and respiratory compromise.<xref ref-type="bibr" rid="article-29170.r7">[7]</xref>&#x000a0;Serial pulmonary function testing is helpful in predicting respiratory insufficiency. Respiratory compromise is suggested by a forced vital capacity (FVC) less than 50% predicted, MIP (maximal inspiratory pressure) less negative than -30 cmH2O, or a maximal expiratory pressure (MEP) below 40 cmH20. Additionally, declines in mental status, bedside capnography (ETC02), and blood gas measurements may be used to monitor for hypercarbia or respiratory acidosis that may indicate impending respiratory failure. Rhabdomyolysis may occur in <italic toggle="yes">M. fulvius</italic> envenomation and should be evaluated as clinical scenario warrants. Unlike pit viper envenomation victims, significant bite area tissue necrosis and coagulopathies are uncommon in coral snake envenomation.</p>
      </sec>
      <sec id="article-29170.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>General treatment measures include ensuring a safe scene (remove from snake exposure), local wound care (although wounds are typically minimal), minimization of movement (relative immobilization in a functional position), avoiding activities that increase heart rate, and promoting patient (and family) relaxation (to decrease systemic propagation of venom). Tetanus prophylaxis is also considered standard in the treatment of snakebites. Pressure immobilization bandage&#x000a0;may be placed over the bite site with just enough force to allow arterial and venous flow but decrease lymphatic flow, potentially decreasing the systemic absorption of coral snake venom through lymphatics.<xref ref-type="bibr" rid="article-29170.r8">[8]</xref><xref ref-type="bibr" rid="article-29170.r9">[9]</xref>&#x000a0;Tourniquets, venom extraction (either by incision and oral suction, manually or by a mechanical device), and cryotherapy are not recommended. If possible, avoid medications that may cause muscle weakness or decreased respiratory function, as these may inhibit the ability to assess for neurotoxic effects due to envenomation.</p>
        <p>Due to the possibility of the delayed onset of life-threatening respiratory compromise, all patients with suspected coral snake envenomation warrant close observation for at least 24 hours at an appropriate level of care for close respiratory monitoring and frequent serial neurologic exams. Patients who demonstrate respiratory insufficiency warrant advanced airway management and treatment with coral snake antivenom and/or other pharmacologic measures, such as anticholinesterases (discussed below). Airway compromise may develop rapidly, so advanced airway medications and equipment should be prepared early and readily available.&#x000a0;</p>
        <p>The North American Coral Snake Antivenin (NACSA) is a horse-derived immunoglobulin (Ig)G antibody used for both <italic toggle="yes">M. fulvius</italic> and <italic toggle="yes">M. tener </italic>envenomation in both adults and children. Its use has not been reported in&#x000a0;patients who are&#x000a0;pregnant. The administration of coral snake antivenom is recommended at the first sign of neurologic deficit or respiratory insufficiency, as some data suggest decreased need for intubation or decreased duration of muscle paralysis and intubation. On the other hand, other data suggest no differences in intubation rates when NACSA is given prophylactically before symptom onset. Administering NACSA empirically to patients without neurologic deficits or respiratory compromise is a controversial decision; however, given the additional risk of immediate and delayed hypersensitivity reactions (discussed below) and mixed clinical evidence results regarding prophylactic antivenom benefit, it is reasonable to procure antivenom early but withhold administration until the development of the first neurologic symptoms.&#x000a0;</p>
        <p>The&#x000a0;best course of action is to contact the Poison Control Center or a toxicologist for treatment guidance. Currently, there is a limited supply of the NACSA, as production ceased in 2006. The known remaining vials of this antivenom have passed the manufacturer&#x02019;s expiration date (2008), but the FDA extended the expiration date through January 31, 2019, for NACSA Lot L67530.<xref ref-type="bibr" rid="article-29170.r10">[10]</xref>&#x000a0;If treatment with antivenom is indicated, contact the Poison Control Center (1-800-222-1222) or a toxicologist for the acquisition of the antivenom and further recommendations. Also, the FDA Office of Vaccines, Blood, and Biologics (301-827-3524) may be contacted for information regarding the risks and benefits of administering expired antivenom. Moreover, it is recommended to contact Poison Control early to assist with the location and mobilization of NACSA, as significant time and mobilization resources may be required to procure it.&#x000a0;<xref ref-type="bibr" rid="article-29170.r11">[11]</xref>&#x000a0;Once the decision is made to administer NACSA, the patient undergoes a test dose of the included horse serum for reactions, and after that, the recommended initial dose of NACSA is three to five vials by slow intravenous push for both adults and pediatrics. Of note, a potential new coral snake antivenom, an equine-based F(ab&#x02019;), is currently in clinical trials in the US. Other antivenoms useful for coral snakes may be available (such as Coralmyn, manufactured in Mexico) and recommended by Poison Control.&#x000a0;<xref ref-type="bibr" rid="article-29170.r12">[12]</xref></p>
        <p>As discussed earlier, NACSA is an equine-based IgG serum, and there is a risk of both immediate and delayed hypersensitivity reactions.&#x000a0;<xref ref-type="bibr" rid="article-29170.r13">[13]</xref> When giving NACSA, clinicians should watch for signs of hives, itching, shortness of breath, hypotension, or angioedema as evidence of an allergic reaction. If patients demonstrate signs of an immediate hypersensitivity reaction, infusion of the antivenom should be stopped immediately, and doses of epinephrine IM (0.3 mg if greater than 30 kg, 0.15 mg if less than 30 kg of the 1:1000 concentration), antihistamine, corticosteroids, and albuterol nebulizers should be given as needed based on clinical symptoms.</p>
        <p>If the patient develops neurotoxicity or respiratory compromise and coral snake antivenom is not available, another pharmacologic treatment option is a trial dose of an anticholinesterase, such as neostigmine. Neostigmine acts by restoring neuromuscular transmission by increasing concentrations of acetylcholine in the neuromuscular junction when weakness is due to the postsynaptic blockade. Pretreatment with atropine or glycopyrrolate should be considered to prevent the potential excessive cholinergic effects of neostigmine. Again, poison control and toxicologist consultation are recommended to guide treatment.&#x000a0;</p>
      </sec>
      <sec id="article-29170.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for&#x000a0;snake toxicity include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anaphylaxis</p>
          </list-item>
          <list-item>
            <p>Deep venous thrombosis</p>
          </list-item>
          <list-item>
            <p>Extremity vascular trauma</p>
          </list-item>
          <list-item>
            <p>Scorpion envenomation</p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Serum sickness</p>
          </list-item>
          <list-item>
            <p>Wasp stings</p>
          </list-item>
          <list-item>
            <p>Wound care</p>
          </list-item>
          <list-item>
            <p>Wound infections</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29170.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about snake toxicity are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Coral snake venom acts by inhibiting acetylcholine receptors at the neuromuscular junction to cause neurotoxic motor weakness.</p>
          </list-item>
          <list-item>
            <p>Life-threatening complications of coral snake bites are related to respiratory muscle weakness and the need for ventilatory support.</p>
          </list-item>
          <list-item>
            <p>Although significant envenomation is uncommon due to the coral snake&#x02019;s less aggressive behavior and difficult mechanism of delivery, the potential of life-threatening respiratory insufficiency delay of up to 13 hours warrants very close observation after a reported exposure.</p>
          </list-item>
          <list-item>
            <p>Although limited in supply and difficult to obtain and transport, coral snake antivenom should be given to all patients bitten by coral snakes regardless of symptoms.</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity reactions to equine-based coral snake antivenom are common, and infusion should be stopped immediately if patients develop adverse reactions.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29170.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of coral snake bites is with an interprofessional team that consists of an emergency department physician, poison control, internist, intensivist, toxicologist, and&#x000a0;intensive care unit nurses. These patients need admission and close monitoring as life-threatening complications of coral snake bites are related to respiratory muscle weakness and the need for ventilatory support. Although significant envenomation is uncommon due to the coral snake&#x02019;s less aggressive behavior and difficult mechanism of delivery, the potential of life-threatening respiratory insufficiency delay of up to 13 hours warrants very close observation after a reported exposure. While limited in supply and difficult to obtain and transport, coral snake antivenom should be given to all patients bitten by coral snakes regardless of symptoms. The outcomes in patients treated with antivenom are excellent, but if there is a delay in treatment, then fatalities are known to occur.<xref ref-type="bibr" rid="article-29170.r3">[3]</xref><xref ref-type="bibr" rid="article-29170.r14">[14]</xref></p>
      </sec>
      <sec id="article-29170.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29170&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29170">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/coral-snake-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29170">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29170/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29170">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29170.s14">
        <fig id="article-29170.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Coral Snake Contributed EJ Wozniak DVM, PhD; Public Health Image Library, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://phil.cdc.gov/Details.aspx?pid=8141">Public Domain</ext-link>, Centers for Disease Control and Prevention</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8141_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29170.s15">
        <title>References</title>
        <ref id="article-29170.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cochran</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dashevsky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arbuckle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Benard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alag&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hendrikx</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Fry</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom.</article-title>
            <source>Neurotox Res</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>487</fpage>
            <page-range>487-495</page-range>
            <pub-id pub-id-type="pmid">28674788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vergara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Romero-Pi&#x000f1;a</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Torres-Viquez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Alag&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Biodistribution and Lymphatic Tracking of the Main Neurotoxin of Micrurus fulvius Venom by Molecular Imaging.</article-title>
            <source>Toxins (Basel)</source>
            <year>2016</year>
            <month>Mar</month>
            <day>26</day>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>85</fpage>
            <pub-id pub-id-type="pmid">27023607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norris</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Pfalzgraf</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Laing</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Death following coral snake bite in the United States--first documented case (with ELISA confirmation of envenomation) in over 40 years.</article-title>
            <source>Toxicon</source>
            <year>2009</year>
            <month>May</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>693</fpage>
            <page-range>693-7</page-range>
            <pub-id pub-id-type="pmid">19673084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vergara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pedraza-Escalona</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Restano-Cassulini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zamudio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Batista</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Possani</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Alag&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Eastern coral snake Micrurus fulvius venom toxicity in mice is mainly determined by neurotoxic phospholipases A2.</article-title>
            <source>J Proteomics</source>
            <year>2014</year>
            <month>Jun</month>
            <day>13</day>
            <volume>105</volume>
            <fpage>295</fpage>
            <page-range>295-306</page-range>
            <pub-id pub-id-type="pmid">24613619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arce-Bejarano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lomonte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: identification of directly hemolytic phospholipases A2.</article-title>
            <source>Toxicon</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>90</volume>
            <fpage>26</fpage>
            <page-range>26-35</page-range>
            <pub-id pub-id-type="pmid">25088177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corbett</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>North American Snake Envenomation.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2017</year>
            <month>May</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>339</fpage>
            <page-range>339-354</page-range>
            <pub-id pub-id-type="pmid">28411931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauch</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>TDS</given-names>
              </name>
              <name>
                <surname>Cesar</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Tomaz</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Monteiro-Machado</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patr&#x000e3;o-Neto</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>True or false coral snake: is it worth the risk? A <italic>Micrurus corallinus</italic> case report.</article-title>
            <source>J Venom Anim Toxins Incl Trop Dis</source>
            <year>2018</year>
            <volume>24</volume>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">29651298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warrell</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Treatment of bites by adders and exotic venomous snakes.</article-title>
            <source>BMJ</source>
            <year>2005</year>
            <month>Nov</month>
            <day>26</day>
            <volume>331</volume>
            <issue>7527</issue>
            <fpage>1244</fpage>
            <page-range>1244-7</page-range>
            <pub-id pub-id-type="pmid">16308385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smyrnioudis</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>O'Rourke</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Meggs</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Long-term efficacy of pressure immobilization bandages in a porcine model of coral snake envenomation.</article-title>
            <source>Am J Emerg Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>9</issue>
            <fpage>1024</fpage>
            <page-range>1024-6</page-range>
            <pub-id pub-id-type="pmid">25059885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mowry</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Spyker</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Cantilena</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>51</volume>
            <issue>10</issue>
            <fpage>949</fpage>
            <page-range>949-1229</page-range>
            <pub-id pub-id-type="pmid">24359283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasaki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Chegondi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raszynski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Totapally</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Coral snake bites and envenomation in children: a case series.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>262</fpage>
            <page-range>262-5</page-range>
            <pub-id pub-id-type="pmid">24694882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Lopez-Johnston</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Acosta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Neutralization of two North American coral snake venoms with United States and Mexican antivenoms.</article-title>
            <source>Toxicon</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">18054059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adukauskien&#x00117;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Varanauskien&#x00117;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Adukauskait&#x00117;</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Venomous snakebites.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2011</year>
            <volume>47</volume>
            <issue>8</issue>
            <fpage>461</fpage>
            <page-range>461-7</page-range>
            <pub-id pub-id-type="pmid">22123554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29170.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wisniewski</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Havey</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bogdan</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Australian tiger snake (Notechis scutatus) and mexican coral snake (Micruris species) antivenoms prevent death from United States coral snake (Micrurus fulvius fulvius) venom in a mouse model.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2003</year>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-10</page-range>
            <pub-id pub-id-type="pmid">12645961</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
